| Title |
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2013
|
| DOI | 10.1002/14651858.cd005226.pub3 |
| Pubmed ID | |
| Authors |
Johannes Brettschneider, Jerome Kurent, Albert Ludolph |
| Abstract |
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is the most common neurodegenerative disorder of the motor system in adults. Pain in ALS is a frequent symptom especially in the later stages of disease and can have a pronounced influence on quality of life and suffering. Treatment of pain therefore should be recognised as an important aspect of palliative care in ALS. This is an update of a review first published in 2008. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | <1% |
| Unknown | 192 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 14% |
| Student > Bachelor | 21 | 11% |
| Student > Ph. D. Student | 19 | 10% |
| Researcher | 15 | 8% |
| Student > Doctoral Student | 15 | 8% |
| Other | 37 | 19% |
| Unknown | 59 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 80 | 41% |
| Nursing and Health Professions | 13 | 7% |
| Psychology | 7 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 17 | 9% |
| Unknown | 65 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2013.
All research outputs
#15,228,078
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,001
of 11,499 outputs
Outputs of similar age
#115,245
of 210,184 outputs
Outputs of similar age from Cochrane database of systematic reviews
#237
of 282 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,184 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 282 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.